NKC Announces Intent To Negotiate Technology Sale to BioSig Technologies

NKC has announced it is negotiation with BioSig Technologies for the sale of some of its IP.

2024 Milestone Progress Update on the Huygens™/ Proteus™ Technology

NKC has released a Milestone Progress Update on the Huygens™/ Proteus™ Technology

2023 End of Year Development Report

NKC has released its End-of-Year Development Report for 2023.

Third Quarter 2023 Development Report

NKC has released its Third Quarter Development Report for 2023.

2022 End-Of-Year Development Report

NKC has released its End-of-Year Development Report for 2022.

Fourth Quarter 2022 Development Report

NKC has released its fourth quarter report for 2022.

Third Quarter 2022 Development Report Released

NKC has released its third quarter development report for 2022.

Abbott Completes The Acquisition Of St. Jude Medical

NKC reports on the acquisition St. Jude Medical by Abbott.

NKC Announces Upcoming Animal Study for Clinical Validation of its Huygens™ – Proteus™ Robotic Arm Surgical Platform

NKC announces animal study to be performed to provide clinical validation of its Huygens™ technology.

Phase One Development Completed

NKC has announced the completion of the Phase One development for its new Huygens™ Smart Catheter and Proteus™ Robotic Arm Platform.

NKC News

The following articles and press releases are to provide information on the current status of the company as well as pertinent related articles on the EP industry. In addition, we also want to provide a historical perspective on the over 20 years of development that has preceded the advent of the new Huygens™ Smart Catheter and the Proteus™ Robotic Guidance System. NKC is very proud of its achievements in the field of advancing catheter mapping tools and guidance systems for the Electrophysiology field.

Specifically, all the articles related to the CGCI technology prior to 2015 relate to the prior work of the company under the Magnetecs banner and do not reflect the current NKC efforts except to show that the company has the ability to move their technology from invention to regulatory acceptance and then to real-world operation. The company is bringing this same expertise to bear on its revolutionary new Smart Catheter and Robotic Guidance System.

 

If you have any questions regarding any information you find here, please contact us at: info@neuro-kinesis.com

President of Madrid Inaugurates CGCI EP Suite

President of Madrid Inaugurates CGCI EP Suite

The inauguration of the electrophysiology lab at Hospital General Universitario La Paz in Madrid, Spain, equipped with the Company’s CGCI Catheter Guidance Control and Imaging (CGCI) system was attended by a variety of noted physicians, scientists and political...

UL Certification Granted for CGCI

UL Certification Granted for CGCI

The CGCI Systcm received product certification from Underwriters Laboratories (UL). Underwriters Laboratories is a trusted organization around the globe for product safety certification and compliance. “Our rapid and efficient UL certification of CGCI validates the...